Boots Antiseptic Wound Wash 0.5% spray

Maa: Yhdistynyt kuningaskunta

Kieli: englanti

Lähde: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiivinen ainesosa:

Cetrimide

Saatavilla:

The Boots Company Plc

ATC-koodi:

D08AJ04

INN (Kansainvälinen yleisnimi):

Cetrimide

Annos:

5mg/1ml

Lääkemuoto:

Cutaneous spray solution

Antoreitti:

Cutaneous

luokka:

No Controlled Drug Status

Prescription tyyppi:

Valid as a prescribable product

Tuoteyhteenveto:

BNF: 13100500; GTIN: 5045096876868

Pakkausseloste

Antiseptic Wound Wash
Cetrimide
PROTECTS AGAINST INFECTION
TREATS CUTS, GRAZES AND INSECT BITES
RELIEVES MINOR BURNS AND SCALDS
100 ML E
READ ALL OF THIS LABEL FOR FULL INSTRUCTIONS.
WHAT THIS MEDICINE IS FOR
This antiseptic wound wash protects against infection and helps to
treat cuts, grazes, insect
bites, minor wounds and spots and also relieve minor burns and scalds.
BEFORE YOU USE THIS MEDICINE
X DO NOT USE:

IF YOU ARE ALLERGIC to any of the ingredients in this medicine

IF YOUR WOUND IS WEEPING, very red or swollen
YOU CAN USE this medicine if you are pregnant or breastfeeding.
 HOW TO USE THIS MEDICINE
Hold the spray upright and spray from a distance of 2 to 4 inches.
ADULTS AND CHILDREN: Spray onto the affected area, and flood to wash
away debris and dirt.
Reapply up to 2 or 3 times a day.
For use on the skin only.
AVOID CONTACT WITH EYES.
Do not use for long periods of time.
If symptoms do not go away talk to your doctor.
If anyone accidentally swallows some: Talk to a pharmacist or doctor.
POSSIBLE SIDE EFFECTS
Most people will not have problems, but some may get some of these:

Skin rash, red or itchy skin (allergic reaction)

Occasionally skin irritation

Please add the following below this sentence:
REPORTING OF SIDE EFFECTS
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any
possible side effects not listed on this label. You can also report
side effects directly via the
Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side
effects you can
help provide more information on the safety of this medicine.
KEEP ALL MEDICINES OUT OF THE SIGHT AND REACH OF CHILDREN.
Use by the date on the edge of the label.
ACTIVE INGREDIENTS
This liquid contains Cetrimide 0.5% w/v.
Also contains: purified water, sodium citrate, disodium edetate,
citric acid.
PL 00014/0507
Text prepared 10/14
Manufactured by the BCM Ltd Nottingham NG2 3AA for the MAH: The Boots
Company PLC
Nottingham NG2 3AA
If you need more advice ask your pharmacist.

Valmisteyhteenveto

OBJECT 1
BOOTS ANTISEPTIC WOUND WASH
Summary of Product Characteristics Updated 15-Jan-2015 | THE BOOTS
COMPANY PLC
1. Name of the medicinal product
First Aid Antiseptic Spray or Boots Antiseptic Wound Wash or Savlon
First Aid Wash 0.5% w/v
Cutaneous Spray, Solution.
2. Qualitative and quantitative composition
Cetrimide 0.5 % w/v
3. Pharmaceutical form
Cutaneous spray, solution (Cutaneous spray)
4. Clinical particulars
4.1 Therapeutic indications
For cuts, grazes, insect bites, minor wounds, spots, minor burns and
scalds.
4.2 Posology and method of administration
For topical application.
Adults, children and the elderly
Hold upright and spray from a distance of 2 to 4 inches on the
affected area.
Spray the affected area two or three times a day.
4.3 Contraindications
Hypersensitivity to any of the ingredients.
4.4 Special warnings and precautions for use
Prolonged and repeated administration may lead to hypersensitivity.
Do not use if the skin is weeping or badly inflamed.
Avoid contact with the eyes.
For external use only.
Keep all medicines out of the reach of children.
4.5 Interaction with other medicinal products and other forms of
interaction
There are no clinically significant interactions.
4.6 Pregnancy and lactation
The safety of First Aid Antiseptic Spray during pregnancy and
lactation has not been established but it is
not considered to constitute a hazard during these periods.
4.7 Effects on ability to drive and use machines
No adverse effects known.
4.8 Undesirable effects
Skin irritation may occasionally occur and hypersensitivity reactions
may develop in certain individuals.
REPORTING OF SUSPECTED ADVERSE REACTIONS
Reporting suspected adverse reactions after authorisation of the
medicinal product is important. It allows
continued monitoring of the benefit/risk balance of the medicinal
product. Healthcare professionals are
asked to report any suspected adverse reactions via the Yellow Card
Scheme at
www.mhra.gov.uk/yellowcard.
4.9 Overdose
It is unlikely that systemic toxicity will result from the in